Verismo Therapeutics Alternatives & Competitors
12 companies similar to Verismo Therapeutics — The team that invented the first FDA-approved CAR-T therapy is back to revolutio...
Companies similar to Verismo Therapeutics
온코인사이트---OncoInsight-Co.,-Ltd.-logo.jpg "(주)온코인사이트 / OncoInsight Co., Ltd."){kind=logo}
Carisma Therapeutics
Pioneering CAR Macrophage Immunotherapy to Target Solid Tumors
Philadelphia, United Stat...
ONK Therapeutics
Pioneering optimally engineered NK cell therapies to cure patients with cancer.
Galway, Ireland
Adicet Bio, Inc
A biotechnology company discovering and developing first-in-class allogeneic gamma delta C...
Redwood City, United Stat...
Track all Verismo Therapeutics competitors
Get real-time alerts when any of these companies raise funding, hire, or show growth signals.
Immugenia Inc.
Developing the next generation CAR therapy using hemopoietic stem cells to treat cancer an...
CERo Therapeutics, Inc.
Tumor Cell Clearance Reimagined.
South San Francisco, Unit...
AltruBio Inc.
Novel Therapeutics for Immunological Diseases
San Francisco, United Sta...
MetiMedi Co., Ltd.
MetiMedi is developing a first-in-class oral immunotherapeutic small molecule in Phase 2 f...
Korea South
3T Biosciences
3T is an immunotherapy company developing next-generation, transformative therapies for br...
South San Francisco, Unit...
Prescient Therapeutics
A clinical stage oncology company developing personalised medicine approaches to cancer; c...
Australia
January Therapeutics
Transformational Oncology
San Diego, United States
Kiromic Biopharma, Inc.
Cell therapy company with end-to-end bioinformatic, AI targeting, and manufacturing techno...
Houston, United States
About Verismo Therapeutics
Verismo Therapeutics is a biotechnology startup founded in 2020, headquartered in the United States. The company's mission, as reflected in their slogan "The team that invented the first FDA-approved CAR-T therapy is back to revolutionize the space with the KIR-CAR," is to pioneer the development of novel chimeric anti...
Verismo Therapeutics, CAR-T Therapy, KIR-CAR, Chimeric Antigen Receptors, Cellular Immunotherapy, Solid Tumors, Pancreatic Cancer, Mesothelioma, Ovarian Cancer, Immuno-oncology, T-cell Exhaustion, SynKIR, Preclinical Development, FDA-approved, Immunologic Receptors
Frequently Asked Questions
Don't just read about them. Follow them.
BounceWatch watches Verismo Therapeutics and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.
Compiled from the BounceWatch company index. We last looked at Verismo Therapeutics on 9 Jun 2026. The 12 companies listed here were last checked between 12 Sep 2024 and 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
